Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study

BACKGROUND: Interstitial lung disease (ILD) is the most common cause of death in patients with systemic sclerosis (SSc). Prognostic biomarkers are needed to identify SSc-ILD patients at risk for progressive pulmonary fibrosis. This study investigates autoantibodies measured in bronchoalveolar lavage...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamberg, Viggo, Sohrabian, Azita, Volkmann, Elizabeth R., Wildt, Marie, Löfdahl, Anna, Wuttge, Dirk M., Hesselstrand, Roger, Dellgren, Göran, Westergren-Thorsson, Gunilla, Rönnelid, Johan, Andréasson, Kristofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476305/
https://www.ncbi.nlm.nih.gov/pubmed/37667402
http://dx.doi.org/10.1186/s13075-023-03141-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476305/
https://www.ncbi.nlm.nih.gov/pubmed/37667402
http://dx.doi.org/10.1186/s13075-023-03141-4

Ejemplares similares